Literature DB >> 3282508

Engineering of antibodies.

M Verhoeyen, L Riechmann.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3282508     DOI： 10.1002/bies.950080207

Source DB:  PubMed          Journal:  Bioessays        ISSN： 0265-9247            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.

Authors:  C H Ford; V J Richardson; V S Reddy
Journal:  Indian J Pediatr       Date:  1990 Jan-Feb       Impact factor: 1.967

Review 3.  [Monoclonal antibodies and mediators--immunologic tumor therapy].

Authors:  D Baron
Journal:  Naturwissenschaften       Date:  1990-09

Review 4.  Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.

Authors:  R M Reilly; J Sandhu; T M Alvarez-Diez; S Gallinger; J Kirsh; H Stern
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

5.  The association of heavy and light chain variable domains in antibodies: implications for antigen specificity.

Authors:  Anna Chailyan; Paolo Marcatili; Anna Tramontano
Journal:  FEBS J       Date:  2011-06-28       Impact factor: 5.542
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.